Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 4, 2004, Pages 940-948

  Kulak, Carolina Aguiar Moreira ^a,c   Borba, Victoria Z C ^a   Bilezikian, John P ^b   Silvado, Carlos E ^a   De Paola, Luciano ^a   Boguszewski, César L ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Columbia University ^*  (United States)

^c UFPR ^*  (Brazil)

Author keywords

25OH vitamin D; Enzyme inducing antiepileptic drugs; Osteomalacia

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; CALCIUM; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CREATININE; LAMOTRIGINE; PARATHYROID HORMONE; PHENOBARBITAL; PHENYTOIN; PHOSPHORUS; VALPROIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; EVALUATION; FEMALE; FEMUR; FOREARM; FRACTURE; HUMAN; INCIDENCE; LIVER FUNCTION TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; RISK FACTOR; SEIZURE; SIDE EFFECT; SMOKING; UNEMPLOYMENT; VITAMIN BLOOD LEVEL;

EID: 10944230397     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000600003     Document Type: Article

References (33)

1. Engel JJ. Epileptic syndromes. In Seizures and epilepsy: Philadelphia: Davis, 1989:195-201.
2. Christiansen C, Rodbro P, Lund, M. Incidence of anticonvulsant osteomalacea and effect of vitamin D; controlled therapeutic trial. Br Med J 1973;4:695-701.
3. Hahn TJ, Hendin BA, Scharp CR, Boisseau VC, Haddad JG. Serum 25-hydroxycaiciferol levels and bone mass in children on chronic anticonvulsivant therapy. N Engl J Med 1975;292:550-554.
4. Valimaki MJ, Tiihonen M, Laitinen K, et al, Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drygs. J Bone Miner Res 1994;9:631-637.
5. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-449.
6. Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-1353.
7. Stephen LJ, McLellan AR, Harrison JH. Bone density and antiepileptic drugs: a case controlled study. Seizure 1999;8:339-342.
8. Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr 1999;38:93-98.
9. Filardis S, Guerreiro CAM, Magna LA, Marques JF Neto. Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr 2000;58:616-620.
10. Bouillon R, Reynaert J, Claes JH, Lissens W, De Moor P. The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab 1975;41:1130-1135.
11. Andress DL, Ozuna J, Tirschwell D, et at. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781-786.
12. Pack AM, Olarte LS, Morrel MM, Flasher E, Stanley RR, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003;4:169-174.
13. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002;43:1488-1492.
14. Thome JF, Cosman F, Lindsay R. Osteoporosis. In Becker KL (ed). Principles and practice of endocrinology and metabology. 2 Ed. Philadelphia: Lippincott, 1995:567-585.
15. Mulder JE, Kulak CAM, Shane E. Secondary osteoporosis. In Seibel MJ, Robins SP, Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. New York: Academic Press 1999;527-545.
16. Valmadri C, Voorhees C, Litt B, Schneyer C. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 2001;58:1369-1374.
17. Desai KB, Ribbans WJ, Talor GJ. Incidence of five common fracture types in an institutional epileptic population. Injury 1996;27:97-100.
18. Nilsson OS, Lindholm TS, Elmestedt E, Lindback A, Lindholm TC. Fracture incidence and bone disease in epileptics receiving long-term anti-convulsant drug treatment. Arch Orthop Trauma Surg 1986;105:146-149.
19. Vestergaard P, Tigaran S, Rejnmark L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999;99:269-275.
20. Lloyd T, Rollings N, Eggli DF, Kieselhorst K, Chinchilli VM Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997;65:1826-1830.
21. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly; means to defining hypovitaminosis D. Osteoporosis Int 1998;8:S3-S6.
22. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
23. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsy 1989;30:389-399.
24. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical e electroencephalographic classification of epileptic seizures. Epilepsy 1981;22:489-501.
25. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996;312:1254-1259.
26. Yasuda H, Shima N, Nakagawa N. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci 1998;95:3597-3602.
27. st century. Am J Clin Nutr 1994;60:619-630.
28. Williams C, Netzloff M, Folkerts L, Vargas A, Garnica A, Frias J. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia. South Med J 1984;77:834-842.
29. Bandeira FA, Bandeira CH, Freese EC. Occult vitamin D deficiency, and its relationship with bone mineral density, among post menopausal women in Recife, Brazil. J Bone and Miner Res 2003;18:(Suppl 2):5407.
30. Fonseca V, Tongia R, El-Hazmi M, Abu-Aisha H. Exposure to sunlight and vitamin D deficiency in Saudi Arabian women. Postgrad Med J 1984;60:(707):589- 591.
31. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxy vitamin D and calcium absorption. J Clin Endocrinol Metab 2002;87:4952-4956.
32. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-806.
33. Heaney RP. Sensitivity of parathyroid hormone response to calcium intake. Am J Clin Nutr. 2003;78:493.